Intramedullary administration of tranexamic acid reduces bleeding in proximal femoral nail antirotation surgery for intertrochanteric fractures in elderly individuals: A randomized controlled trial.
10.1016/j.cjtee.2024.01.006
- Author:
Xiang-Ping LUO
1
;
Jian PENG
2
;
Ling ZHOU
2
;
Hao LIAO
2
;
Xiao-Chun JIANG
2
;
Xiong TANG
2
;
Dun TANG
2
;
Chao LIU
2
;
Jian-Hui LIU
2
Author Information
1. Department of Orthopaedic, Hengyang Central Hospital, Hengyang, 421001, Hunan province, China. Electronic address: luoxiangping8@sina.com.
2. Department of Orthopaedic, Hengyang Central Hospital, Hengyang, 421001, Hunan province, China.
- Publication Type:Randomized Controlled Trial
- Keywords:
Blood loss;
Intertrochanteric fractures;
Tranexamic acid;
Transfusion
- MeSH:
Humans;
Tranexamic Acid/administration & dosage*;
Hip Fractures/surgery*;
Male;
Aged;
Female;
Fracture Fixation, Intramedullary/adverse effects*;
Blood Loss, Surgical/prevention & control*;
Antifibrinolytic Agents/administration & dosage*;
Aged, 80 and over;
Bone Nails;
Middle Aged;
Blood Transfusion/statistics & numerical data*
- From:
Chinese Journal of Traumatology
2025;28(3):201-207
- CountryChina
- Language:English
-
Abstract:
PURPOSE:Intertrochanteric fractures undergoing proximal femoral nail antirotation (PFNA) surgery are associated with significant hidden blood loss. This study aimed to explore whether intramedullary administration of tranexamic acid (TXA) can reduce bleeding in PFNA surgery for intertrochanteric fractures in elderly individuals.
METHODS:A randomized controlled trial was conducted from January 2019 to December 2022. Patients aged over 60 years with intertrochanteric fractures who underwent intramedullary fixation surgery with PFNA were eligible for inclusion and grouped according to random numbers. A total of 249 patients were initially enrolled, of which 83 were randomly allocated to the TXA group and 82 were allocated to the saline group. The TXA group received intramedullary perfusion of TXA after the bone marrow was reamed. The primary outcomes were total peri-operative blood loss and post-operative transfusion rate. The occurrence of adverse events was also recorded. Continuous data was analyzed by unpaired t-test or Mann-Whitney U test, and categorical data was analyzed by Pearson Chi-square test.
RESULTS:The total peri-operative blood loss (mL) in the TXA group was significantly lower than that in the saline group (577.23 ± 358.02 vs. 716.89 ± 420.30, p = 0.031). The post-operative transfusion rate was 30.67% in the TXA group and 47.95% in the saline group (p = 0.031). The extent of post-operative deep venous thrombosis and the 3-month mortality rate were similar between the 2 groups.
CONCLUSION:We observed that intramedullary administration of TXA in PFNA surgery for intertrochanteric fractures in elderly individuals resulted in less peri-operative blood loss and decreased transfusion rate, without any adverse effects, and is, thus, recommended.
